Golgin-160 belongs to the golgin family of Golgi localized proteins, which have been implicated in Golgi structure and function. Golgin-160 possesses an N-terminal non-coiledcoil "head"domain followed by an extensive coiled-coil region. Using the N-terminal head domain of golgin-160 as bait in a yeast twohybrid screen, the postsynaptic density-95/Discs large/zona occludens-1 (PDZ) domain protein interacting specifically with TC10 (PIST) was identified to interact with golgin-160. PIST (also known as GOPC, CAL and FIG) has been implicated in the trafficking of a subset of plasma membrane proteins, supporting a role of golgin-160 in vesicular trafficking. Golgin-160 and PIST colocalize to Golgi membranes, and interact in vivo. GST binding experiments identified an internal region of PIST that includes a coiled-coil domain, which interacts directly with golgin-160. Similar binding experiments identified a leucine rich repeat within golgin-160 necessary for interaction with PIST. Therefore, our data suggest that golgin-160 may participate in PIST-dependent trafficking of cargo. Interestingly, we also discovered a widely expressed isoform of golgin-160, golgin-160B, which lacks the exon encoding the leucine repeat that mediates binding to PIST. As predicted, golgin-160B was unable to bind PIST. Full-length golgin-160 and golgin-160B may link distinct subsets of proteins to effect specific membrane trafficking pathways.
The mammalian Golgi complex is composed of polarized stacks of cisternal membranes connected by tubules to form a reticular network of membranes located in a juxtanuclear position (1) . Transport through the Golgi apparatus allows for posttranslational modification of proteins and lipids as cargo sequentially encounters modifying enzymes before being sorted to its final destination. While the importance of Golgi structure in the proper and efficient transport of secretory cargo is well documented, understanding how Golgi structure and function are coupled remains an active area of research.
The golgin family of Golgi-localized proteins has been implicated in both Golgi structure and function. Members of the golgin family were first identified as autoantigens in patients with autoimmune diseases, but the family has been expanded to include any Golgi-localized protein that contains an extensive coiled-coil region. The golgin family of proteins includes peripheral membrane proteins such as GM130 (2) , golgin-45 (3), golgin-97 (4), golgin-160 (5, 6) , and golgin-230/245 (7, 8) , as well as the integral membrane proteins, golgin-67 (9), golgin-84 (10), and giantin (11) .
GM130 and giantin are the best-studied golgins. GM130 associates with Golgi membranes by binding to GRASP65, an N-ethylmaleimidesensitive cis-Golgi membrane protein important for cisternal stacking (12) . Giantin in transport vesicles is thought to interact via p115 with GM130-GRASP65 in a Rab1-dependent manner (13) . The tethering of giantin-containing vesicles with cisternal membranes containing GM130-GRASP65 is proposed to increase the specificity and/or efficiency of soluble NSF-attachment protein receptor (SNARE)-mediated recognition and fusion of transport vesicles (14) .
A number of other golgins have also been implicated in the maintenance of Golgi structure and function. A medial-Golgi complex containing GRASP55 and golgin-45 was identified (3) . Depletion of golgin-45 by RNA interference results in Golgi disassembly and inhibition of secretory protein transport. Depletion of golgin-84 leads to Golgi fragmentation and to reduced cell surface expression of the vesicular stomatitis virus G protein (15) . Similarly, depletion of another golgin, golgin-97, results in Golgi fragmentation and inhibition of cholera toxin B fragment retrograde trafficking from the endosome-to-TGN (16) . Taken together, these results suggest that golgins and the proteins with which they interact link Golgi structure and membrane trafficking.
Golgin-160 is a peripheral membrane protein localized to the cytoplasmic face of the Golgi complex. Golgin-160 possesses an Nterminal non-coiled-coil (head) domain, which contains Golgi targeting information (17) , and a Cterminal coiled-coil domain, comprising twothirds of the protein. Previous work showed that caspase cleavage of the head of golgin-160 is required for the efficient disassembly of the Golgi during programmed cell death and the propagation of specific apoptotic signals (18, 19) . Interestingly, caspase cleavage of the N-terminal head of golgin-160 may allow for nuclear translocation of golgin-160 fragments from the Golgi to the nucleus during apoptosis (17) . If caspase-derived fragments of golgin-160 are translocated to the nucleus, they may function to regulate apoptotic progression.
In this study, we used the N-terminal head domain of golgin-160 as bait in a yeast two-hybrid screen to identify protein interactors. Here we identify and characterize the binding of golgin-160 with PDZ domain protein interacting specifically with TC10 (PIST). We also show that a novel isoform of golgin-160, golgin-160B, which is widely expressed in human tissues, is unable to bind PIST. Our results suggest that different golgin-160 isoforms may play non-overlapping roles in the regulation of certain membrane trafficking pathways.
MATERIAL & METHODS
Yeast Two-hybrid Assay -Yeast twohybrid screening was performed using the Matchmaker Gal4 Two-Hybrid System 3 and a Matchmaker pretransformed HeLa cDNA library following the manufacturer's instructions (Clontech, Palo Alto, CA). The bait plasmid, human golgin-160 N-terminus (amino acid residues 1-393), was amplified by PCR from a previously described full-length clone of human golgin-160 (18) . The PCR fragment was cloned into the bait vector pGBKT7 (Clontech) using SalI and NdeI restriction sites, and transformed into yeast strain AH109 (Clontech). The yeast strain Y187 (pretransformed with a cDNA library from HeLa cells cloned into the vector pGAD-GH) was mated with the AH109 strain that contained the bait construct according to the manufacturer's protocol. About 1x10 7 HeLa clones were screened on both high stringency (lacking adenine, leucine, tryptophan, and histidine) and medium stringency (lacking leucine, tryptophan, and histidine) plates. Surviving clones that tested positive for bglactosidase expression were isolated and sequenced. A cDNA encoding residues 74 to 454 of human PIST (BC009553) was identified.
Expression Constructs -Myc-tagged golgin-160 and truncation mutants have been described (17) . A full-length cDNA clone of GFPtagged human PIST was kindly provided by William B. Guggino (Johns Hopkins University). Mutant proteins were named with both the tag type and the amino acids represented. The sequences of mutant proteins were confirmed by dideoxy sequencing. PIST truncation mutants were cloned into the Bgl II and EcoRI restriction sites of a modified pEGFP-C1 vector (T7-EGFP-C1) in which we inserted the T7 promoter sequence, TAATACGACTCACTATAGGG, upstream of the GFP start codon as previously described (17) . Individual PIST truncation mutants were generated by PCR amplification to introduce a 5' BamHI site and a 3' EcoRI site, followed by ligation into the T7-EGFP-C1 vector. To create the leucine repeat mutant in golgin-160 (g160(1-3 9 3 ) 3 L A / m y c ) t h e s e q u e n c e LQSLRLSLPMQETQLCSTDSPL beginning at amino acid 121 was changed to AQSLRLSAPMQETQACSTDSPL using PCRbased QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). The delta exon 3 isoform mutants, of golgin-160 (g160B(1-1459)/myc and g160B(1-353)/myc) were generated by PCR mutagenesis using a primer overlapping the alternative splice junction. Glutathione-S-transferase (GST) fusion proteins containing the non-coiled-coil head domain of golgin-160, GST/g160(1-393), and the full-length PIST fusion protein, GST/PIST(1-454) were cloned into pGEX-2T (Amersham Biosciences, Piscataway, NJ).
Cells and Antibodies
HeLa cells were maintained in Dulbecco's modified Eagles medium (DMEM, Invitrogen, Carlsbad, CA) containing 10% fetal calf serum and 0.1 mg/ml normocin-O (InvivoGen, San Diego, CA) at 37°C in 5% CO 2 . Thirty-five mm dishes of HeLa cells (70-80% confluent) were transfected with 6 ml LT-1 (Mirus, Madison, WI) and 2mg of T7-EGFP and/or pcDNA3.1/MycHis(+), (Invitrogen) encoding the appropriate cDNA. Steady state expression was analyzed 16 h after transfection.
Rabbit anti-golgin-160 has been described (17) . Polyclonal goat antibodies to PIST were from Abcam Inc (Cambridge, MA). Mouse antip115 was from BD Transduction labs (San Jose, CA). Rabbit anti-alpha mannosidase II (ManII) was a gift from Kelly Moremen (University of Georgia) and Marilyn Farquhar (University of California, San Diego). Rabbit anti-GFP was from Molecular Probes (Eugene, Oregon) and mouse anti-c-myc was from Sigma (St. Louis, MO). Texas Red-conjugated goat anti-rabbit and antimouse IgG, and fluorescein-conjugated goat antirabbit and anti-mouse IgG were from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA). Horesradish peroxidase (HRP)-conjugated secondary antibodies were from Amersham.
Indirect immunofluorescence microscopyFor localization studies, HeLa cells were stained as previously described (17) . Briefly, cells were fixed in 3% paraformaldehyde for 10 m and permeabilized with 0.5% Triton X-100 in 10 mM glycine in phosphate-buffered saline (Gly/PBS) for 3 m. Coverslips were incubated in primary antibody diluted in Gly/PBS plus 1% bovine serum albumin (BSA) (or 1% fish skin gelatin for goat anti-PIST) for 20 m. Coverslips were washed 3 times with Gly/PBS, incubated with fluoresceinor Texas Red-labeled secondary antibodies, and washed as above. Coverslips were then mounted in glycerol containing 0.1 M N-propyl gallate. Images were collected on an Axioskop microscope (Zeiss, Thornwood, NY) equipped with epifluorescence and a Sensys CCD camera (Photometrics, Tucson, AZ) using IP Lab software (Signal Analytics, Vienna, VA).
C o -i m m u n o p r e c i p i t a t i o n a n d Immunoblotting -The method used for immunoprecipitation has been described previously (17) . Briefly, cells were lysed in 25 mM Hepes (pH 7.1), 125 mM potassium acetate, 1.0% Nonidet P-40, 1 mM dithiothreitol (DTT) with a protease inhibitor cocktail (Sigma). Cell lysates were cleared of debris by centrifugation at 2000 x g for 10 m, and lysates were immunoprecipitated with 2 ml of anti-GFP or antimyc antiserum. Immune complexes were collected with either 25 ml of fixed Staphylcoccus aureus (Calbiochem-Novabiochem, La Jolla, CA) or 20 m l of Protein G-Sepharose (Amersham B i o s c i e n c e s ) a n d w a s h e d .
T h e immunoprecipitates were analyzed by SDS-PAGE and visualized by immunoblot analysis as described below.
For immunoblotting analysis, proteins were separated on SDS-polyacrylamide gels (PAGE) and transferred to Immobilon-P Transfer Membrane (Millipore, Billerica, MA). Membranes were blocked in 3% BSA, 0.1% Tween 20, 150 mM NaCl, and 10 mM Tris (pH 7.4) for 1 h and then incubated with the indicated primary antibody blocking buffer overnight at 4°C. The blots were washed and incubated for 1 h at room temperature with the appropriate horseradish peroxidaseconjugated secondary antibody (Amersham Biosciences) in blocking buffer. The membranes were washed and analyzed using enzyme-linked chemiluminescence with the ECL kit (Amersham Biosciences). Chemiluminescent signal was measured by the VersaDoc Imaging System (BioRad, Hercules, CA) and quantitated using Quantity One software (BioRad).
GST Pull-down Assays-For GST pulldown assays, the head domain of golgin-160 and full-length PIST were expressed as GST fusion proteins in Escherichia coli BL21-codon plus (Stratagene, La Jolla, CA) using standard methods.
Bacterially expressed GST or GST-fusion proteins were purified and rebound to glutathioneSepharose 4B beads according to the manufacturer's instructions (Pharmacia Biotech). [
35 S]methionine-labeled golgin-160, PIST and truncation mutants were generated by coupled in vitro transcription/translation using the TNT" T7 coupled reticulocyte lysate system (Promega, Madison, WI) as instructed by the manufacturer. The [
35 S]-labeled proteins were incubated with GST or GST-fusion protein coupled beads in binding buffer (25 mM Hepes (pH 7.1), 125 mM potassium acetate, 1 mM DTT) overnight at 4°C. Beads were washed three times with binding buffer containing 0.1% NP-40. Proteins were eluted, electrophoresed, and visualized on a Molecular Imager FX phosphoimager (BioRad) and quantitated using Quantity One software (BioRad).
RT-PCR and Quantitative Real Time PCR -Total RNA from human tissues was obtained from Clontech. Total RNA from HeLa cells was isolated using TRIzol® total RNA isolation reagent (Invitrogen, Gaithersburg, MD) following the manufacturer's instructions. Total HeLa RNA was quantified by absorbance at 260 nm in a spectrophotometer, and purity was assessed by the 260/280 absorbance ratio. cDNA was synthesized using 1 μg of RNA reverse-transcribed with 200 units of MLV reverse transcriptase (Invitrogen) in a 20-μl reaction containing 25 ng of oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer, 500 μM of each dNTP, 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , and 10 mM DTT.
To identify golgin-160 transcripts in HeLa cells, a region within the N-terminal head domain was amplified by PCR. The primers used to visualize golgin-160 isoform expression in HeLa cells were as follows: golgin-160 (GenBank accession number NM_005895), forward 5'-TGGTGCCACCTGACCAGCAGGACAAA-3' (sense, 101-126nt) and reverse 5'-C T T A C C A A G G G C C A G T A C C C T G -3 ' (antisense, 612-591 nt). PCR reactions were carried out with Taq polymerase buffer (Invitrogen) with 2.5 mM MgCl 2 , 0.4 mM each dNTP, and 10 pmol of each primer. Amplification (denaturation 94°C, 30 seconds; annealing 55°C, 30 seconds; extension 72°C, 60 seconds) was performed in a DNA thermal cycler (PerkinElmer Life Sciences, model 2400). PCR products were run on a 1.5% agarose gel, excised, and purified. PCR products were sequenced as described.
Quantitative real-time PCR was used to quantitate mRNA encoding golgin-160 isoforms. The isoform specific primers used were as follows: golgin-160 A (GenBank NM_005895), f o r w a r d 5 ' -GCAGTCTCTCAGACTCAGTCTTCC-3' (sense, 363-386 nt) and golgin-160 B, forward 5'-TGATGCCTCTCCAGGCTCTAC A-3' (sense, 271-294 nt) and the reverse primer 5'-CTTACCAAGGGCCAGTACCCTG -3' (g160A: 612-591 nt) was used for both isoform A and B of golgin-160. mRNA expression levels of each golgin-160 isoform was quantified by real-time PCR using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA) and an MyCycler Thermal Cycler (Bio-Rad) according to the manufacturer's instructions. Myi software (Bio-Rad) was used to auto calculate threshold cycles (Tc). mRNA levels were normalized to the Tc of 1 ng of the corresponding isoform plasmid cDNA. Expression levels were expressed as the mRNA level relative to golgin-160 isoform A in HeLa cells, which was given a relative mRNA quantity of 1.0. PCR amplification was performed two independent times.
RESULTS

PIST interacts with golgin-160 in vivo -
We previously identified an 85 amino acid stretch in the N-terminal head domain of golgin-160 containing Golgi targeting information (17) . While the head domain of golgin-160 shows no significant homology to other proteins, it contains several interesting motifs, including a cryptic nuclear localization signal (residues, 232-239) and three caspase cleavage sites (D59, D139, and D311) (Fig. 1A) . In order to identify candidate proteins that interact with golgin-160, a yeast twohybrid screen was performed using the N-terminal non-coiled coil head domain of golgin-160 as bait.
We screened approximately 1 X 10 7 clones of a pretransformed HeLa cell cDNA library and isolated a clone encoding the PDZ domain protein interacting specifically with TC10 (PIST) (Fig.  1B) . The interaction between golgin-160 and PIST was further confirmed by b-galactosidase activity following co-transformation of the individual cDNAs into yeast (data not shown). PIST was first identified due to its interaction with TC10, a Rho GTPase (20). PIST, also known as GOPC (Golgi associated PDZ and coiled-coil motif containing) (21) , CAL (CFTR (cystic fibrosis transmembrane conductance receptor)-associated ligand) (22) , and FIG (fused in glioblastoma)(23) , contains two N-terminal coiled-coil domains and a PDZ domain within its C-terminal half (Fig. 1C) . PIST is suggested to have a role in the trafficking of a subset of plasma membrane proteins through interactions with its PDZ domain (22) (23) (24) (25) .
Immunofluorescence microscopy verified that endogeneous PIST is localized to the Golgi complex in HeLa cells, closely overlapping the localization of golgin-160 ( Fig. 2A) . To confirm the interaction between PIST and golgin-160 detected by the yeast two-hybrid system, coimmunoprecipitations were carried out. We cotransfected HeLa cells with plasmids encoding GFP/PIST(1-454) and g160(1-1498)/myc. Lysates from co-transfected HeLa cells were immunoprecipitated with anti-GFP antibody followed by immunoblotting for myc-tagged golgin-160 or the endogenous Golgi protein, p115 (as a negative control). Golgin-160 was strongly and specifically co-immunoprecipitated with PIST (Fig. 2B) , demonstrating that PIST and golgin-160 can interact in cells. Endogenous golgin-160 could also be co-immunoprecipitated from nontransfected HeLa cells with anti-PIST antibodies (data not shown).
Identification of a 127 amino acid sequence within PIST that directly interacts with golgin-160 -To determine which region of PIST bound golgin-160, we performed in vitro binding experiments. We created a GST-tagged fusion protein of the head of golgin-160 (GST/g160(1-393)), the same region used as bait in the yeast two-hybrid screen. Full-length and truncated versions of [
35 S]methionine-labeled PIST (Fig.  3A) were generated by coupled in vitro transcription and translation, and then incubated with GST alone or GST/g160(1-393). Full-length PIST bound efficiently and specifically to the head of golgin-160 (Fig. 3B) . PIST truncations consisting of either the first 145 amino acids (GFP/PIST (1-145) ) or the last 180 amino acids (GFP/PIST(274-454)) of PIST were unable to bind to the head of golgin-160, indicating that these regions do not directly interact with golgin-160. By contrast, GFP/PIST(146-273) specifically bound to golgin-160.
However, neither the second coiled-coil region of PIST (GFP/PIST(146-202)) or the linker region preceeding the PDZ domain (GST/PIST(203-274)) alone was able to bind golgin-160. Therefore, a 127 amino acid segment of PIST consisting of the second coiledcoil domain and the region preceding the PDZ domain is sufficient to mediate direct binding of PIST to golgin-160.
A leucine repeat within the head domain of golgin-160 is necessary for interaction with PIST. -To narrow down the sequence within the head of golgin-160 responsible for binding to PIST, we performed similar in vitro binding experiments using GST-tagged full-length PIST (GST/PIST(1-454) instead of GST/golgin-160. [
35 S]methionine-labeled myc-tagged golgin-160 proteins (Fig. 4A) were produced by coupled in vitro transcription and translation and then incubated with GST alone or GST/PIST(1-454). As expected, the full-length and N-terminal head domain of golgin-160 were able to bind to PIST, while the C-terminal coiled-coil domain was unable to bind (Fig 4A) . To further map the interaction domain within the head of golgin-160, progressively smaller truncations of the head, as illustrated in Fig. 4B , were tested for their ability to bind PIST. g160(60-311)/myc was able to interact with PIST as efficiently as the full head domain (Fig. 4B) . Interestingly, neither g160(1-139)/myc nor g160(140-311)/myc bound to PIST, suggesting that the sequences flanking residue 139 may mediate golgin-160 binding to PIST.
A closer look at the sequence surrounding residue 139 in golgin-160 revealed a leucine repeat (L-X 6 -L-X 6 -L-X 6 -L) located between amino acids 121 and 141 (Fig. 5A) . To test the contribution of the leucine repeat to golgin-160-PIST interaction, we introduced three leucine-toalanine substitutions, L121A, L128A, and L135A, into g160(1-393)/myc to create g160(1-393)3LA/myc (Fig. 5A) . Mutation of three of four leucines has been shown to disrupt dimerization via leucine repeats (26, 27) . We chose alanines to disrupt potential hydrophobic interactions with PIST, while minimizing structural changes to the head of golgin-160. Whereas the wild-type head of golgin-160 binds to PIST, mutation of the leucine repeat (g160(1-393)3LA/myc) significantly inhibited in vitro binding to PIST (Fig. 5B) . Therefore the leucine repeat in the head of golgin-160 is critical for the direct interaction of golgin-160 with PIST.
Identification and quantitation of a splice isoform of human golgin-160 lacking exon 3. -Interestingly, the reference sequence for the murine golgin-160 protein (Mea-2; NP_032172) encodes a 1447 amino acid protein that lacks the exon encoding the leucine repeat (designated exon 3 in humans). Mea-2 apparently represents an alternative splice variant of golgin-160 in which exon 3 is absent. However, a mouse cDNA clone (BAA86889) containing exon 3 is present in the National Center of Biotechnology Information nucleotide database. This suggests that mice express at least two isoforms of golgin-160 that differ by the presence or absence of exon 3. A database search of human expressed sequence tags (ESTs) indicates that humans also express an isoform of golgin-160 lacking exon 3, similar to Mea-2 ( Fig. 6A) . At least five human ESTs of significant E value containing this alternative splice isoform exist. To confirm that human cells express an isoform of golgin-160 missing exon 3, RT-PCR was carried out on HeLa cells and human tissues. cDNA was reverse transcribed from total RNA using an oligo(dT) primer followed by PCR amplification. Primers used in the PCR reaction were complementary to sequences in exon 2 (sense) and exon 4 (anti-sense). HeLa cells and all the tissues analyzed showed two PCR products (Fig. 6B) . The difference in PCR product size corresponds to the size of exon 3. The bands were extracted and sequenced, confirming that the observed RT-PCR products represent amplification of golgin-160A (full-length, upper band) and golgin-160B (missing exon 3, lower band). Although golgin-160 runs as a doublet on SDS-PAGE gels, this is a result of phosphorylation (28) . We were unable to distinguish between the golgin-160 isoforms following phosphatase treatment by SDS-PAGE using our existing antibodies (data not shown).
In order to determine the ratio of golgin-160 isoforms, quantitative real-time RT-PCR was performed. Primers were engineered to specifically amplify either the golgin-160A isoform or the golgin-160B isoform. Both golgin-160A and golgin-160B were expressed in all tissues examined, with the highest expression of both isoforms in testis (Fig. 6C) . While golgin-160A was the predominant transcript in most tissues, a significant amount of golgin-160B mRNA transcript was also observed in each. The ratio of golgin-160A to golgin-160B varied from a 1:1 ratio in lung to a 2:1 ratio in testis.
The golgin-160B isoform localizes to the Golgi but is unable to bind PIST. -Previous work has demonstrated that the minimal Golgi targeting information in golgin-160A does not overlap with exon 3 (17) . Therefore, both isoforms share the region shown to contain Golgi targeting information. To confirm that the Golgi targeting information is functional and golgin-160B is localized to the Golgi, we expressed a myc-tagged version of golgin-160 lacking exon 3, g160B(1-1458)/myc, in HeLa cells (Fig. 7A) . Colocalization of g160B(1-1458)/myc and mannosidase II, a Golgi resident enzyme, by indirect immunofluorescence microscopy verified that golgin-160B is specifically targeted to the Golgi complex.
Since golgin-160B lacks the leucine repeat, we predicted that golgin-160B would be unable to bind PIST. To test this, we performed in vitro binding assays with GST/PIST(1-454), as described above. We expressed a myc-tagged protein corresponding to the head domain of golgin-160B (g160B(1-353)/myc). The [ 35 S]methionine-labeled head domains of both isoform A , g160(1-393)/myc, and isoform B, g160B(1-353)/myc, were examined for their ability to bind GST/PIST(1-454). Unlike golgin-160A, golgin-160B was unable to bind PIST (Fig.  7B) .
DISCUSSION
Golgin-160 is a peripheral membrane protein that belongs to the golgin family of Golgilocalized proteins. A number of recent studies have implicated golgins in the maintenance of Golgi structure and the integrity of membrane trafficking pathways. We previously showed that the N-terminal non-coiled-coil domain head domain of golgin-160 possesses Golgi targeting information (17) . The head domain of golgin-160 is also cleaved by caspases during apoptosis, and this cleavage is required for apoptotic progression induced by specific stimuli and efficient disassembly of the Golgi complex (18, 19) . Taken together, these results suggest that the N-terminal head domain of golgin-160 mediates protein-To gain further insight into the role of golgin-160 in Golgi structure and function, we sought to identify proteins that interact with golgin-160. We performed a yeast two-hybrid screen using the N-terminal non-coiled-coil domain of golgin-160 as bait. We found that the PDZ domain containing protein, PIST, interacts with the head of golgin-160. In addition to a PDZ domain in the C-terminal half of the protein, PIST also contains two N-terminal coiled-coil domains. PIST colocalized with golgin-160 at the Golgi complex in HeLa cells (Fig. 2A) , and coimmunoprecipitation confirmed that golgin-160 and PIST can interact in vivo (Fig. 2B) .
We performed in vitro binding assays and identified a 127 amino acid region within PIST that directly interacts with golgin-160 (Fig. 3B) . The C-termini of several plasma membrane proteins, including the b1-adrenergic receptor, (29) , CFTR (30), the chloride channel, ClC-3B (31), glutamate receptor delta2 (32) , and Frizzled-5 and -8 (21), interact with the PDZ domain of PIST. By contrast, the second coiled-coil domain and the linker sequence preceeding the PDZ domain of PIST is necessary and sufficient to bind to golgin-160. This same region of PIST has been reported to mediate interactions with TC10, a Rho GTPase, (20) and syntaxin-6, a Q-SNARE (23) . Recently, exogeneous expression of TC10 has been proposed to regulate CFTR trafficking and expression through its interaction with PIST (34) . Therefore binding of golgin-160, TC10 and syntaxin-6 to PIST may coordinate membrane trafficking of some plasma membrane proteins in cell types where these proteins are expressed. Since TC10 is not widely expressed (35) , it will be important to analyze its effect on PIST function in cells that normally express TC10.
Using in vitro binding experiments, we identified a leucine repeat motif within the head of golgin-160 necessary for the direct interaction of golgin-160 with PIST (Fig 5) . While this repeat is characteristic of leucine zipper motifs, the leucine repeat in golgin-160 does not possess the predicted coiled-coil structure required for leucine zipper regulated dimerization. Furthermore, we previously showed that the head of golgin-160 does not homodimerize (17) . Therefore, it is unlikely that the leucine repeat found within the head of golgin-160 is a classical leucine zipper. Although unable to mediate homodimerization, these leucines are required for golgin-160-PIST interaction. Within the segment of PIST that binds golgin-160, there is also a leucine zipper motif located in the second coiled-coil domain. Even though we were unable to detect an interaction between the second coiled-coil domain of PIST and golgin-160, we propose that a heterodimeric interaction of the leucine repeat of golgin-160 and the leucine zipper of PIST is likely necessary but not sufficient for golgin-160-PIST interaction.
The head domain of golgin-160 is cleaved during programmed cell death by caspases (18) . Protein cleavage by caspases has been proposed to disrupt protein-protein interactions that are critical for protein function, contributing to apoptosis. Caspase-3 has been shown to cleave golgin-160 at D139, which is located within the region required for the interaction of golgin-160 and PIST. Fusion proteins that mimic cleavage products of golgin-160 generated by caspase-3 cleavage at D139 (g160(1-139)/myc and g160(140-311)/myc) were unable to bind PIST (Fig. 4B) . Therefore, caspase cleavage of golgin-160 during apoptosis is likely to disrupt golgin-160-PIST interaction, which may contribute to Golgi disassembly and/or progression of apoptosis.
Interestingly, the annotated mouse homolog of golgin-160, Mea-2, lacks exon 3. Quantitative real time RT-PCR confirmed that an alternative transcript of human golgin-160 lacking exon 3 is widely expressed in human tissues (Fig.  6 ) and localizes to the Golgi complex (Fig. 7A) . Surprisingly, golgin-160B mRNA levels ranged from 50% to 100% of the level of golgin-160A mRNA. With our current antibodies we are unable to resolve golgin-160 isoforms by SDS-PAGE. An antibody specific for exon 3 will allow us to specifically analyze golgin-160A.
The alternative splicing that occurs in golgin-160B may prevent caspase-3 cleavage at D99 (corresponding to D139 in golgin-160A). Aside from the requirement for Asp the position 1 (P1), the amino acid present three residues upstream of the Asp (P4) is the most critical determinant of specificity (36) . Due to the alternative splicing in golgin-160B, the cysteine at P4 of golgin-160A, is replaced by a glycine at P4 in golgin-160B. Use of a combinatorial peptide library demonstrated that a glycine at P4 severely inhibits caspase-3 cleavage (36) . In addition, Mea-2, the mouse homolog of human golgin-160B, encodes an Ala in place of the required Asp (residue 99). Therefore, it is likely that caspase-3 is unable to cleave human golgin-160B at D99 or the mouse homolog, Mea-2. Studies are currently underway to characterize the caspase cleavage of golgin-160B and its consequences.
Since golgin-160B lacks three of the leucines necessary for interaction with PIST, we predicted that golgin-160B would be unable to interact with PIST. In vitro binding experiments confirmed that golgin-160B was unable to bind PIST (Fig. 7B ). Therefore, it is possible that golgin-160B functions independently of PIST, or that heterodimers of golgin-160A and golgin-160B may organize different binding partners into complexes.
Our findings raise the possibility that golgin-160 may play a role in the transport of proteins bound to the PDZ domain of PIST. It also suggests that caspase cleavage of golgin-160 may disrupt this transport step and aid in Golgi disassembly and/or apoptotic progression. Furthermore, the ratio of golgin-160 isoforms in a given cell may allow for the regulation of PISTdependent trafficking of cargo. Studies to address the role of golgin-160 in the trafficking of plasma membrane proteins that bind PIST are currently underway. Figure 1. Identification of PIST as a golgin-160 interactor by yeast two-hybrid assay. A) The N-terminal "head" domain (residues 1-393) of golgin-160 was fused to GAL4 binding domain and used to screen a HeLa library for interactors. The head domain has been enlarged to highlight interesting motifs contained within this region. The gray bars represent the location of Golgi targeting and putative nuclear retention information, and the gray box the nuclear localization signal (NLS). Caspase-cleavage sites are marked with arrowheads. B) Alignment of the partial protein sequence of positive interacting clone #25 with the full-length human (AAH09553) and mouse (NP_444417) PIST protein sequences. C) A diagram of full-length PIST containing the two N-terminal coiled-coil domains (CC1 and CC2) and the C-terminal PDZ domain (PDZ). Figure 2 . Golgin-160 and PIST co-localize to the Golgi complex and can be coimmunoprecipitated. A) HeLa cells were fixed, permeabilized and double-labeled with rabbit anti-golgin-160 and goat anti-PIST antibody. Secondary antibodies were fluorescein-conjugated donkey anti-rabbit IgG and Texas Red-conjugated donkey anti-goat IgG. Bar, 10 mm. B) HeLa cells were co-transfected with GFP-tagged PIST and myc-tagged golgin-160. Cell lysates were immunoprecipitated with anti-GFP. 10% of the total lysate, immunoprecipitates, and 10% of the unbound fraction were analyzed by SDS-PAGE and immunoblotted with anti-GFP, anti-myc, and anti-p115. A) Schematic representation of the head of golgin-160B, a splice isoform lacking exon 3. The amino acid sequence in the region where the alternative splicing event occurs is shown (deleted exon 3 is shown above). B) mRNA expression of golgin-160 isoforms. Total RNA from HeLa cells and indicated human tissues was reverse transcribed. Primers were used to PCR amplify a region that would include exon 3. PCR products were analyzed by electrophoresis in an agarose gel. Amplicons representing isoform A and isoform B were present in HeLa cells and all tissues examined. C) mRNA expression levels of golgin-160 isoforms. Quantitative real-time PCR was performed with primers specific for either golgin-160A or golgin-160B as desribed in "Material and Methods". Results were normalized to the amplification of 1 ng of plasmid cDNA encoding the corresponding isoform. All values are presented as the mRNA level relative to that of golgin-160 isoform A in HeLa cells, which was given a relative mRNA level of 1.0. Error bars represent the standard deviation from two independent experiments. Figure 7 . Golgin-160B localizes to the Golgi but is unable to bind PIST. A) HeLa cells were transfected with myc-tagged golgin-160A or myc-tagged golgin-160B. Cells were fixed, permeabilized, and stained with mouse anti-myc and rabbit anti-mannosidase II (ManII) antibodies. Secondary antibodies were Texas Red-conjugated goat anti-mouse IgG and fluorescein-conjugated donkey anti-rabbit IgG. Bar, 10 mm. B) The ability of the golgin-160B isoform to bind PIST was tested. In vitro interaction of golgin-160A and golgin-160B isoforms with a GST-fusion protein containing full-length PIST. g160A(1-393)/myc and g160B(1-353)/myc were [
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35 S] methionine-labeled by in vitro transcription/translation and incubated with bacterially expressed GST/PIST(1-454) bound to glutathione-sepharose. Bound proteins were visualized by phosphorimaging.
